title: Administration of green tea or caffeine enhances the disappearance of UVB-induced patches of mutant p53 positive epidermal cells in SKH-1 mice.
abstract: Irradiation of female SKH-1 hairless mice with UVB (30 mJ/cm2) twice a week for 10-20 weeks resulted in the formation of a large number of cellular patches (>8 adjacent cells/patch) that are recognized with an antibody (Pab240) which recognizes mutated but not wild-type p53 protein. These patches are not recognized by an antibody (Pab1620) to wild-type p53 protein. The patches, which are considered putative early cellular markers of the beginning of tumor formation, started appearing after 4-6 weeks of UVB treatment, and multiple patches were observed after treatment for 10 weeks. The number and size of the patches increased progressively with continued UVB treatment. Discontinuation of UVB for 4 weeks resulted in an 80-90% decrease in the number of these patches. The number of the remaining patches did not decrease any further but remained relatively constant for at least 4-9 weeks. Oral administration of green tea (6 mg tea solids/ml) or caffeine (0.4 mg/ml) as the sole source of drinking fluid during irradiation with UVB, twice a week for 20 weeks, inhibited UVB-induced formation of mutant p53 positive patches by approximately 40%. Oral administration of green tea (6 mg tea solids/ml) as the sole source of drinking fluid or topical applications of caffeine (6.2 micromol) once a day 5 days a week starting immediately after discontinuation of UVB treatment enhanced the rate and extent of disappearance of the mutant p53-positive patches. Topical applications of caffeine to the dorsal skin of mice pretreated with UVB for 20 weeks resulted in enhanced apoptosis selectively in focal basal cell hyperplastic areas of the epidermis (putative precancerous lesions), but not in areas of the epidermis that only had diffuse hyperplasia. Our studies indicate that the chemopreventive effect of caffeine or green tea may occur by a proapoptotic effect preferentially in early precancerous lesions.
authors.affiliation: Susan Lehman Cullman Laboratory for Cancer Research, Department of Chemical Biology, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, 164 Frelinghuysen Road, Piscataway, NJ 08854-8020, USA.
authors.forename: Yao-Ping
authors.initials: YP
authors.lastname: Lu
authors.forename: You-Rong
authors.initials: YR
authors.lastname: Lou
authors.forename: Jie
authors.initials: J
authors.lastname: Liao
authors.forename: Jian-Guo
authors.initials: JG
authors.lastname: Xie
authors.forename: Qing-Yun
authors.initials: QY
authors.lastname: Peng
authors.forename: Chung S
authors.initials: CS
authors.lastname: Yang
authors.forename: Allan H
authors.initials: AH
authors.lastname: Conney
mesh_terms: D000284:Administration, Oral; D000818:Animals; D000918:Antibody Specificity; D002110:Caffeine / Q000008:administration & dosage / Q000494:pharmacology*; D004817:Epidermis / Q000187:drug effects / Q000473:pathology / Q000528:radiation effects*; D007150:Immunohistochemistry; D051379:Mice; D008812:Mice, Hairless; D013662:Tea; D016159:Tumor Suppressor Protein p53 / Q000235:genetics* / Q000528:radiation effects; D014466:Ultraviolet Rays
chemical_list: D013662:Tea; D016159:Tumor Suppressor Protein p53; D002110:Caffeine